# Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension

> **NCT05647473** · PHASE2 · UNKNOWN · sponsor: **Fujian Medical University Union Hospital** · enrollment: 66 (estimated)

## Conditions studied

- Orthostatic Hypotension
- Alzheimer Disease

## Interventions

- **BEHAVIORAL:** Routine treatment
- **DRUG:** add-on low dose Astragalus
- **DRUG:** add-on high dose Astragalus

## Key facts

- **NCT ID:** NCT05647473
- **Lead sponsor:** Fujian Medical University Union Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-20
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647473, "Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05647473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*